|
|
||||||||
Clinical Chemistry, Vol 41, 1814-1818, Copyright © 1995 by American Association for Clinical Chemistry
M Lotti
Istituto di Medicina del Lavoro, Universita degli Studi di Padova, Italy.
Cholinesterases are measured to assess exposures to or effects of organophosphorus esters and carbamates. Plasma butyrylcholinesterase is usually most sensitive to inhibitors, but it has no known physiological function(s); its inhibition reflects exposure. The physiological function of erythrocyte acetylcholinesterase (AChE) also is not known, but the enzyme is the same as that involved in synaptic transmission and its measurement is used to mirror effects on the nervous system. Erythrocyte AChE has large inter- and intraindividual variation, and small changes are detectable by comparison with preexposure values. The relation between inhibition of erythrocytes and nervous tissue AChE depends on the pharmacokinetics of inhibitors. Usually, erythrocyte AChE inhibition overestimates that in the nervous system. Pharmacodynamic factors such as spontaneous reactivation and aging of inhibited enzyme should also be considered in assessing AChE inhibition. Other factors, such as timing of measurement, add complexity because erythrocyte AChE inhibition persists longer than that in the nervous tissues. Cholinergic transmission might also be impaired because of direct effects of organophosphorus esters and carbamates on receptors.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Eddleston, P. Eyer, F. Worek, M.H. Rezvi Sheriff, and N.A. Buckley Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning QJM, June 1, 2008; 101(6): 467 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Tsakiris, P Angelogianni, C Tesseromatis, S Tsakiris, and K H Schulpis Effect of L-carnitine administration on the modulated rat brain protein concentration, acetylcholinesterase, Na+K+-ATPase and Mg2+-ATPase activities induced by forced swimming Br. J. Sports Med., May 1, 2008; 42(5): 367 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, D. Wang, J. Zheng, Y. An, Q. Wang, W. Zhang, L. Jin, H. Gao, and L. Lin Effect of (R)-Salsolinol and N-Methyl-(R)-Salsolinol on the Balance Impairment Between Dopamine and Acetylcholine in Rat Brain: Involvement in Pathogenesis of Parkinson Disease Clin. Chem., April 1, 2008; 54(4): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Lefkowitz, J. M. Kupina, N. L. Hirth, R. M. Henry, G. Y. Noland, J. Y. Barbee Jr, J. Y. Zhou, and C. B. Weese Intraindividual Stability of Human Erythrocyte Cholinesterase Activity Clin. Chem., July 1, 2007; 53(7): 1358 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M Roberts and C. K Aaron Management of acute organophosphorus pesticide poisoning BMJ, March 24, 2007; 334(7594): 629 - 634. [Full Text] [PDF] |
||||
![]() |
B. Antonijevic and M. P. Stojiljkovic Unequal Efficacy of Pyridinium Oximes in Acute Organophosphate Poisoning Clin. Med. Res., March 1, 2007; 5(1): 71 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raheja and K. Dip Gill Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain Toxicology and Industrial Health, February 1, 2007; 23(1): 25 - 37. [Abstract] [PDF] |
||||
![]() |
P. Grandjean, R. Harari, D. B. Barr, and F. Debes Pesticide Exposure and Stunting as Independent Predictors of Neurobehavioral Deficits in Ecuadorian School Children Pediatrics, March 1, 2006; 117(3): e546 - e556. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Hawkins, R. D. Egleton, and T. P. Davis Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H212 - H219. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. H. Bueters, M. J. A. Joosen, H. P. M. van Helden, A. P. IJzerman, and M. Danhof Adenosine A1 Receptor Agonist N6-Cyclopentyladenosine Affects the Inactivation of Acetylcholinesterase in Blood and Brain by Sarin J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1307 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Schulpis, G. A. Karikas, J. Tjamouranis, H. Michelakakis, and S. Tsakiris Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria Clin. Chem., October 1, 2002; 48(10): 1794 - 1796. [Full Text] [PDF] |
||||
![]() |
G. J A Ohayo-Mitoko, H. Kromhout, J. M Simwa, J. S M Boleij, and D. Heederik Self reported symptoms and inhibition of acetylcholinesterase activity among Kenyan agricultural workers Occup. Environ. Med., March 1, 2000; 57(3): 195 - 200. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |